October 20, 2021

The U.S. FDA has amended the emergency use authorizations (EUAs) for COVID-19 vaccines to expand the use of booster shots in eligible individuals.

  • A single booster dose of the Moderna COVID-19 vaccine or the Pfizer COVID-19 vaccine (marketed under the brand name Comirnaty®) can be administered at least six months after completion of the primary series to individuals:
    • 65 years of age and older;
    • 18 through 64 years of age at high risk of severe COVID-19; or
    • 18 through 64 years of age with frequent institutional or occupational exposure to SARS- CoV-2, the virus that causes COVID-19.
  • A single booster dose of the Janssen (Johnson & Johnson) COVID-19 vaccine can be administered at least two months following completion of the single-dose primary regimen to individuals 18 years of age and
  • Each of the three COVID-19 vaccines available in the United States (Pfizer/BioNTech, Moderna, and Janssen) can be mix-and-matched to provide a booster dose in eligible individuals who received a different COVID-19 vaccine for primary
    • For instance, an individual who received primary vaccination with the Moderna vaccine can receive a booster dose of the Pfizer/BioNTech or Janssen vaccines if needed.
November 19, 2021

COVID-19 Booster Shots Authorized for All Adults

Read More
November 18, 2021

New Warning Added to Climara Pro Prescribing Information

Read More
November 15, 2021

Besremi Approved for Rare Cancer

Read More
November 15, 2021

Mvasi Receives New Cancer Indication

Read More